Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model

Clinical and Experimental Immunology

Volumn 138, Issue 3, 2004, Pages 375-387

  Chen, L ^a   Martinez, O ^a   Overbergh, L ^b   Mathieu, C ^b   Prabhakar, B S ^a   Chan, Lawrence S ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atopic dermatitis; Cytokine; Real time PCR; Th1; Th2

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DNA MICROARRAY; FLOW CYTOMETRY; KERATINOCYTE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTIGENS, CD3; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DNA; INTERLEUKIN-4; INTERLEUKINS; KERATINOCYTES; LEUKOCYTES, MONONUCLEAR; MAST CELLS; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TH1 CELLS; TH2 CELLS; UP-REGULATION;

EID: 9644302965     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02649.x     Document Type: Article

References (62)

1. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361:151-60.
2. Leung DYM, Jain N, Leo HL. New concepts in the pathogenesis of atopic dermatitis. Curr Opin Immunol 2003; 15:634-8.
3. Hanifin JM. Immunologic aspects of atopic dermatitis. Dermatol Clin 1990; 8:747-50.
4. Cooper KD, Stevens SR. T cells in atopic dermatitis. J Am Acad Dermatol 2001; 45(Suppl. 1): S10-12.
5. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102:128-37.
6. - memory T cells. J Immunol 1997; 159:4611-9.
7. Akdis M, Trautmann A, Klunker S et al. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 2003; 17:1026-35.
8. + peripheral T cells of patients with atopic dermatitis. Br J Dermatol 2002; 147:1135-41.
9. Boguniewicz M, Leung DY. Atopic dermatitis: a question of balance. Arch Dermatol 1998; 134:870-1.
10. Campbell DE, Hill DJ, Kemp AS. Enhanced IL-4 but normal interferon-gamma production in children with isolated IgE mediated food hypersensitivity. Pediatr Allergy Immunol 1998; 9:68-72.
11. Chan SC, Brown MA, Willcox TM et al. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element. J Invest Dermatol 1996; 106:1131-6.
12. Chan SC, Li SH, Hanifin JM. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 1993; 100:681-4.
13. Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19:359-61.
14. Kallmann BA, Kolb H, Huther M, Martin S, Hellermann M, Lampeter EF. Interleukin-10 is a predominant cytokine in atopic dermatitis. Arch Dermatol 1996; 132:1133-4.
15. Kawashima T, Noguchi E, Arinami T et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998; 35:502-4.
16. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001; 117:977-83.
17. Willemse T. Atopic skin disease: a review and a reconsideration of diagnostic criteria. J Small Anim Pract 1986; 27:771-8.
18. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92:44-7.
19. Grewe M, Gyufko K, Schöpf E, Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 343:25-6.
20. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98:225-31.
21. Nuttall TJ, Knight PA, McAleese SM, Lamb JR, Hill PB. T-helperl, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis. Vet Immunol Immunopathol 2002; 87:379-84.
22. Vestergaard C, Yoneyama H, Murai M et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999; 104:1097-105.
23. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999; 103:1103-11.
24. Li XM, Sampson HA. Experimental mouse model of atopic dermatitis: induction by oral allergen. In: Chan LS, ed. Animal models of human inflammatory skin diseases. Boca Raton: CRC Press, 2004:399-415.
25. Callard R, George AJ, Stark J. Cytokines, chaos, and complexity. Immunity 1999; 11:507-13.
26. Lee F, Yokota T, Otsuka T et al. Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sci USA 1986; 83:2061-5.
27. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003; 14:33-43.
28. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25:386-401.
29. Elbe-Burger A, Egyed A, Olt S et al. Overexpression of IL-4 alters the homeostasis in the skin. J Invest Dermatol 2002; 118:767-78.
30. Lever WF, Schaumburg-Lever G. Histopathology of the skin, 6th edn. Philadelphia: J.B. Lippincott Co., 1983:99.
31. Tani H, Morris RJ, Kaur P. Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 2000; 97:10960-5.
32. Chen L, Venkataramani P, Martinez O, Lin SX, Prabhakar BS, Chan L. The dynamic movement of inflammatory cells between secondary lymphoid organs and the skin in an animal model of atopic dermatitis. FASEB J 2004; 18:A191.
33. + T cell-predominated inflammatory infiltrate associated with up-regulation of adhesion molecules. J Invest Dermatol 2003; 121 [Abstract 44].
34. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94:870-6.
35. Nuttall TJ, Knight PA, McAleese SM, Lamb JR, Hill PB. Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis. Clin Exp Allergy 2002; 32:789-95.
36. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101:1614-22.
37. Dearman RJ, Basketter DA, Evans P, Kimber I. Comparison of cytokine secretion profiles provoked in mice by glutaraldehyde and formaldehyde. Clin Exp Allergy 1999; 29:124-32.
38. Dearman RJ, Warbrick EV, Skinner R, Kimber I. Cytokine finger-printing of chemical allergens: species comparisons and statistical analyses. Food Chem Toxicol 2002; 40:1881-92.
39. Hayashi M, Higashi K, Kato H, Kaneko H. Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and BALB/c. Toxicol Appl Pharmacol 2001; 177:38-45.
40. Vandebriel RJ, De Jong WH et al. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4. Toxicol Appl Pharmacol 2000; 162:77-85.
41. Korpelainen EI, Gamble JR, Vadas MA, Lopez AF. IL-3 receptor expression, regulation and function in cells of the vasculature. Immunol Cell Biol 1996; 74:1-7.
42. Bessler H, Bergman M, Salman H. Interleukin-3 and stress. Biomed Pharmacother 2000; 54:299-304.
43. Takatsu K. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev 1998; 9:25-35.
44. Takamatsu Y, Hasegawa M, Sato S, Takehara K. IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis. Dermatology 1998; 196:377-81.
45. Ansel JC, Luger TA, Lowry D, Perry P, Roop DR, Mountz JD. The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol 1988; 140:2274-8.
46. Luger TA, Kock A, Kirnbauer R, Schwarz T, Ansel JC. Keratinocyte-derived interleukin 3. Ann NY Acad Sci 1988; 548:253-61.
47. Sprecher E, Becker Y. Detection of IL-1 beta, TNF-alpha, and IL-6 gene transcription by the polymerase chain reaction in keratinocytes, Langerhans cells and peritoneal exudate cells during infection with herpes simplex virus-1. Arch Virol 1992; 126:253-69.
48. Cumberbatch M, Dearman RJ, Kimber I. Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology 1996; 87:513-8.
49. Kolde G, Schulze-Osthoff K, Meyer H, Knop J. Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis. Arch Dermatol Res 1992; 284:154-8.
50. Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 149:92-5.
51. Chan LS, Hammerberg C, Kang K, Sabb P, Tavakkol A, Cooper KD. Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interleukin-1 beta (IL-1 beta) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism. J Invest Dermatol 1992; 99:315-22.
52. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003; 112:1058-66.
53. Asadullah K, Docke WD, Haeussler A, Sterry W, Volk HD. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. J Invest Dermatol 1996; 107:833-7.
54. Ohmen JD, Hanifin JM, Nickoloff BJ et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995; 154:1956-63.
55. Novak N, Allam JP, Hagemann T et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2004; 114:364-70.
56. Schreiber S, Kilgus O, Payer E et al. Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 1992; 149:3524-34.
57. Jung K, Linse F, Heller R, Moths C, Goebel R, Neumann C. Adhesion molecules in atopic dermatitis: VCAM-1 and ICAM-1 expression is increased in healthy-appearing skin. Allergy 1996; 51:452-60.
58. Patel KD. Eosinophil tethering to interleukin-4-activated endothelial cells requires both P-selectin and vascular cell adhesion molecule-1. Blood 1998; 92:3904-11.
59. Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 1991; 146:592-8.
60. Cumberbatch M, Dearman RJ, Griffiths CE, Kimber I. Langerhans cell migration. Clin Exp Dermatol 2000; 25:413-8.
61. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol 2001; 116:633-40.
62. Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8:157-65.